Skip to content
TREVENTIS™ Corporation
  • Home
  • About Us
    • Board of Directors
    • Advisory Board
  • Pipeline
    • Tau Oligomer Inhibitors (3R/4R)
    • p53 Oligomer Inhibitor
    • Broad Spectrum TDP Oligomer Inhibitor
  • Technology
    • Protein Misfolding: The Basics
    • Treventis’ CCM Technology
  • Therapeutic Areas
    • Tauopathy Diseases
    • Cancer
    • Amyotrophic Lateral Sclerosis (ALS)
    • Other Protein Misfolding Diseases
  • News & Publications
    • News
    • Publications
    • Social Media
  • Careers
  • Partners & Collaborators
  • Contact Us
TREVENTIS™ Corporation
TREVENTIS™ Corporation > News & Publications > News
  • Share
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
    •  
  • Print

News

January 15, 2018

Treventis Diagnostics highlighted in recent press articles

The Treventis diagnostics program, headed by neurologist and medicinal chemist Dr. Sultan Darvesh, was recently featured in two news articles:...
Read More
May 11, 2017

TREVENTIS becomes a resident of JLABS @ Toronto

May 11, 2017 – Toronto, ON – TREVENTIS has become a resident of JLABS @ Toronto. JLABS@ Toronto is a...
Read More
« Previous 1 2 3
    • News & Publications
    • News
    • Publications
    • Social Media

Quick Links

  • Home
  • About Us
  • Contact Us

Social Links

  • Twitter
  • Linkedin
Copyright © Treventis Corporation. | Site Map
Website by Axxiem